Glioblastoma is the development of cancer among glial cells in the central nervous system and is the most common form of brain cancer in Canada. Current treatment for glioblastoma consists of a combination of surgery, radiotherapy, and chemotherapy; however, Optune (Novocure), a medical device, has recently become available in Canada for the treatment of glioblastoma. Optune uses the emerging therapy of tumour- treating fields to target growth of cancerous cells. CADTH is conducting an evidence review of the technology to examine the value of this therapy in treatment.
To enhance the quality and relevance of this work, CADTH is seeking to engage people with personal or professional experience with treatment of glioblastoma in Canada. Specifically, CADTH is interested to engagein engaging with health care professionals (e.g., oncology specialists, oncology nurses, social workers, pharmacists, administrators, leadership) and people with experience (e.g., patients, family members, caregivers) with the treatment and management of glioblastoma. In this instance, CADTH is seeking people with the ability to:
- contribute to the diversity of perspectives through awareness of others’ experiences and views within the patient or professional community (for example, experience with a professional or patient association, or as a volunteer, staff member, or board member)
- act with integrity, independent of specific interests
- work constructively as a member of a diverse team.
There are a limited number of engagement opportunities available to support this work, including as an expert consultant, peer reviewer, or committee member. The time commitment will vary depending on the role, with engagement activities expected to occur between August 2023 and January 2024. An honorarium will be provided to those selected for the project.
In addition to the engagement opportunities described here, there will be other opportunities to provide input; (for example, through calls for stakeholder feedback).
If selected for this project, we will communicate with you primarily by email. Meetings are held in English through Zoom or Teams, link or by toll-free telephone.
Statement of Interest